Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3s79 | ASD | Aromatase | 1.14.14.14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3s79 | ASD | Aromatase | 1.14.14.14 | 1.000 | |
| 4dvq | 1CA | Cytochrome P450 11B2, mitochondrial | 1.14.15.4 | 0.546 | |
| 4k9v | 6AW | Cytochrome P450 3A4 | / | 0.509 | |
| 3tjs | D0R | Cytochrome P450 3A4 | / | 0.505 | |
| 3nxu | RIT | Cytochrome P450 3A4 | / | 0.498 | |
| 3wec | AUI | Cytochrome P450 | / | 0.498 | |
| 4enh | FVX | Cholesterol 24-hydroxylase | / | 0.493 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.491 | |
| 4uym | VOR | 14-alpha sterol demethylase Cyp51B | / | 0.490 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.485 | |
| 5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.484 | |
| 3ibd | CPZ | Cytochrome P450 2B6 | 1.14.13 | 0.481 | |
| 3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.473 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.472 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.472 | |
| 2j0d | ERY | Cytochrome P450 3A4 | / | 0.469 | |
| 4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.468 | |
| 1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.465 | |
| 3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.463 | |
| 1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.459 | |
| 3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.459 | |
| 3ua1 | 08Y | Cytochrome P450 3A4 | / | 0.459 | |
| 1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.458 | |
| 1suo | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.458 | |
| 3oew | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.456 | |
| 1m13 | HYF | Nuclear receptor subfamily 1 group I member 2 | / | 0.454 | |
| 1zid | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
| 3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.454 | |
| 4bqp | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
| 2cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
| 3t3q | 9PL | Cytochrome P450 2A6 | 1.14.13 | 0.453 | |
| 2qo6 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.451 | |
| 4cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.451 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.450 | |
| 4ejg | NCT | Cytochrome P450 2A13 | 1.14.14.1 | 0.450 | |
| 1iwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 3t3r | 9PL | Cytochrome P450 2A6 | 1.14.13 | 0.448 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.447 | |
| 3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
| 1t85 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 1uyu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 3l63 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
| 2a1n | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
| 2nv6 | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
| 1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 4l49 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 2qbn | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 2qo4 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.440 | |
| 5cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 |